![David Fuller](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Fuller
Director Técnico/Científico/I+D en
DIMERIX LIMITED
.
Perfil
David Fuller is Chairman at EpiAxis Therapeutics Pty Ltd. since 2020.
Dr. Fuller is Chief Medical Officer at Dimerix Ltd. since 2023.
Former roles include Non-Executive Director at Linear Clinical Research Ltd., Non-Executive Director at AdAlta Ltd. from 2020 to 2026, and Chief Medical Officer at Racura Oncology Ltd. from 2021 to 2022.
Education includes an undergraduate degree from The University of Sydney.
Cargos activos de David Fuller
| Empresas | Cargo | Inicio |
|---|---|---|
| DIMERIX LIMITED | Director Técnico/Científico/I+D | 01/10/2023 |
EpiAxis Therapeutics Pty Ltd.
 EpiAxis Therapeutics Pty Ltd. BiotechnologyHealth Technology Develops clinical drugs for breast cancer | Presidente | 01/07/2020 |
Antiguos cargos conocidos de David Fuller.
| Empresas | Cargo | Fin |
|---|---|---|
| ADALTA LIMITED | Director/Miembro de la Junta | 17/04/2026 |
| RACURA ONCOLOGY LTD | Director Técnico/Científico/I+D | 11/11/2022 |
Dimerix Bioscience Pty Ltd.
 Dimerix Bioscience Pty Ltd. Pharmaceuticals: MajorHealth Technology Develops therapy for chronic kidney disease | Director/Miembro de la Junta | - |
Linear Clinical Research Ltd. | Director/Miembro de la Junta | - |
Formación de David Fuller.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
22
Relaciones de 1er grado
7
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 7 |
|---|---|
The University of Sydney
 The University of Sydney Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dimerix Ltd.
 Dimerix Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research and development of biopharmaceutical drugs | Health Technology |
AdAlta Ltd.
 AdAlta Ltd. BiotechnologyHealth Technology Discovers and develops i-body drugs to treat fibrotic diseases | Health Technology |
Linear Clinical Research Ltd. | |
Dimerix Bioscience Pty Ltd.
Dimerix Bioscience Pty Ltd. Pharmaceuticals: MajorHealth Technology Develops therapy for chronic kidney disease | Health Technology |
Race Oncology Ltd.
 Race Oncology Ltd. Pharmaceuticals: MajorHealth Technology Manufactures drugs for cancer | Health Technology |
EpiAxis Therapeutics Pty Ltd.
EpiAxis Therapeutics Pty Ltd. BiotechnologyHealth Technology Develops clinical drugs for breast cancer | Health Technology |
- Bolsa de valores
- Insiders
- David Fuller
